FDA accepts BLA for Priority Review of Opdivo + Yervoy in first-line NSCLC

Our challenge: To find zen in chaos

This column is a love letter of sorts to our field, a recognition of all that we have accomplished and an acknowledgement that we need to find a path forward that supports and empowers the best of what it is to invest in cancer research.

January 31, 2025

By W. Kimryn Rathmell

Guest Editorial

Foundations acquire a critical new role as federal funding for cancer research falters

The fight against cancer is complex. It’s global. And it’s indisputably expensive.

January 31, 2025

By Ryan Schoenfeld and Raymond N. DuBois

Guest Editorial

Cancer research fuels life-saving work

Over the past century, groundbreaking cancer research in the U.S. has led to life-saving medical advances that benefit patients worldwide. Scientists often devote their lives to making discoveries, putting their scientific endeavors ahead of status, income, or lifestyle. Investigators work tirelessly, often seven days a week, to solve complex medical problems. These efforts often lead to game-changing outcomes that help us understand difficult medical challenges, advance technologies and develop new therapies.

January 31, 2025

By Ze’ev Ronai

NCI study: Prevention and screening saved more lives than treatment in five common cancer types over the past half-century

Over the last 45 years, prevention and screening interventions have made a greater contribution to averting cancer deaths than have improvements in treatment, according to a modeling study led by researchers at NCI.

January 31, 2025

By Yiqing Wang and Jacquelyn Cobb

Less taxing therapies taking center stage

Advances such as new nontoxic, more effective immunotherapy and improvements that significantly reduce recovery times for complicated surgeries are making cancer treatments less taxing. On the horizon are more ways to give patients the greatest chance of survival while also reducing negative consequences of treatment. Some therapies also will improve the experience, such as chemotherapy consisting of quick subcutaneous injections instead of hours in an infusion chair.

January 31, 2025

By City of Hope staff

In the Archives

Ted Kennedy, RFK Jr.’s uncle, shaped the National Cancer Program. Will his nephew follow suit?

“The historic National Cancer Act of 1971 has often been called ‘Nixon’s War on Cancer,’ but it could as easily have been called ‘Kennedy’s War on Cancer,’ and with perhaps greater justification,” writes Richard Rettig, a historian of the National Cancer Act (The Cancer Letter, May 23, 2008).

January 31, 2025

FDA accepts BLA for Priority Review of Opdivo + Yervoy in first-line NSCLC

YOU MAY BE INTERESTED IN

Our challenge: To find zen in chaos

Foundations acquire a critical new role as federal funding for cancer research falters

Cancer research fuels life-saving work

NCI study: Prevention and screening saved more lives than treatment in five common cancer types over the past half-century

Less taxing therapies taking center stage

Ted Kennedy, RFK Jr.’s uncle, shaped the National Cancer Program. Will his nephew follow suit?

Renew today!

Subscriber content

Never miss an issue!

Login